A - Human Necessities – 61 – L
Patent
A - Human Necessities
61
L
A61L 29/16 (2006.01) A61L 29/08 (2006.01) A61L 29/10 (2006.01) A61M 1/00 (2006.01) A61M 1/04 (2006.01) A61M 25/00 (2006.01) A61M 31/00 (2006.01)
Patent
CA 2703849
Methods and systems for treating pleural disease comprising a providing a low dosage of a sclerosing agent over a period of time. Certain examples include catheter with a sclerosing agent that is inserted into the pleural space. The sclerosing agent is released in a sustained-release manner over a period of time to achieve diffuse pleurodesis of the pleural layers.
L'invention concerne des procédés et des systèmes permettant de traiter une maladie pleurale par administration d'une faible dose d'agent sclérosant pendant une durée prédéterminée. Dans certains exemples, un cathéter contenant un agent sclérosant est inséré dans un espace pleural, puis l'agent sclérosant est libéré de manière contrôlée pendant une durée prédéterminée afin de d'obtenir une pleurodèse diffuse des couches pleurales.
Dumitriu Severian
Tremblay Alain
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Universite de Sherbrooke
Uti Limited Partnership
LandOfFree
Method and system for sustained-release of sclerosing agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and system for sustained-release of sclerosing agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and system for sustained-release of sclerosing agent will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1911599